Affiliation:
1. Institute of Nephrourology, Bangalore, Karnataka, India
Abstract
Among men one of the most common cancers identified globally is prostate cancer. Although the serum prostate specific antigen remains important for prognosis and diagnosis, the PSA assay is not highly accurate. In the search for improved minimally invasive methods as a biomarker, the expression patterns of circulating miRNAs have a potential importance and are emerging as a promising candidate as prognostic markers for prostate cancer.
Publisher
IP Innovative Publication Pvt Ltd
Reference14 articles.
1. Vanacore D, Boccellino M, Rossetti S, Cavaliere C, D'Aniello C, Franco, RD, Micrornas in prostate cancer: an overview.Oncotarget 201725;8(30):50240-51
2. .GLOBOCAN 2018: estimated cancer incidence, mortality and prevalence worldwide in 2018.
3. Rebbeck TR, Prostate Cancer Genetics: Variation by Race, Ethnicity, and Geography.Semin Radiat Oncol 2017;27(1):3-10
4. Siegel RL, Miller KD, Jemal A, Cancer statistics, 2015.CA Cancer J Clin 2015;65(1):5-29
5. Descotes JL, Diagnosis of prostate cancer.Asian J Urol 2019;6(2):129-36